| Literature DB >> 29977174 |
Marieke Lindenschot1,2,3,4, Imelda J M de Groot4, Saskia Koene5, Ton Satink2,3,6, Esther M J Steultjens2,3, Maria W G Nijhuis-van der Sanden1,4.
Abstract
BACKGROUND: Engagement in everyday activities is important for the health and wellbeing of children. Children with mitochondrial disorders have impaired energy production leading to limitations in activity. It is unknown which activities these children perform and if the nature of activities of low-functioning children differs from average-functioning children. Therefore, this pilot study explored the activities reported in patient records of a heterogeneous group of children with genetically confirmed mitochondrial disorders.Entities:
Mesh:
Year: 2018 PMID: 29977174 PMCID: PMC6011071 DOI: 10.1155/2018/5716947
Source DB: PubMed Journal: Occup Ther Int ISSN: 0966-7903 Impact factor: 1.448
Clinical and genetic characteristics of the children.
| Gender (A) | Age (years) | Level of cognitive development (B) | Level of motor development (C) | Score on Hoffer scale (D) | Level of speech ability (E) | Level of functional abilities of daily activities (F) | Fatigue score (G) | Gene (H) | Mutation |
|---|---|---|---|---|---|---|---|---|---|
| Profile: global low functioning ( | |||||||||
| F | 5 | 1 | 2 | 1 | 4 | 2 | 71 |
| c.910C>T |
| M | 6 | 1 | 3 | 1 | 1 | 1 | 40 |
| c.1361A>C |
| M | 12 | 1 | 2 | 2 | 3 | 2 | 49 |
| c.64-2A>G |
| M | 18 | 1 | 2 | 1 | 3 | 3 | ? |
| c.442A>G; c.1519G>A |
| M | 18 | 1 | 2 | 3 | 3 | 2 | 49 |
| m.09176T>C |
|
| |||||||||
| Profile: low cognitive functioning and moderate to normal ambulation ( | |||||||||
| M | 13 | 2 | 4 | 4 | 6 | 4 | 58 |
| m.3243A>G |
| F | 13 | 1 | 2 | 5 | 5 | 3 | ? |
| c.442A>G; c.1519G>A |
| M | 14 | 1 | 3 | 5 | 3 | 2 | 49 |
| c.626C>T; c.766C>T |
| M | 16 | 1 | 3 | 4 | 2 | 3 | 32 |
| m.8993T>G |
| F | 17 | 1 | 3 | 5 | 6 | 4 | 54 |
| m.3243A>G |
|
| |||||||||
| Profile: global moderate functioning ( | |||||||||
| M | 4 | 3 | 3 | 4 | 5 | 3 | 65 |
| c.788_794del |
| M | 4 | 3 | 4 | 4 | 3 | 3 | 72 |
| m.8993T>G |
| F | 5 | 3 | 3 | 4 | 6 | 3 | 72 |
| c.364G>A |
| F | 5 | 3 | 4 | 4 | 6 | 3 | 39 |
| m.3243A>G |
| M | 7 | 3 | 2 | 4 | 6 | 3 | 66 |
| m.09185T>C |
| M | 7 | 3 | 4 | 4 | 6 | 3 | 38 |
| m.7507A>G |
| M | 13 | 3 | 3 | 4 | 5 | 4 | 58 |
| m.3243A>G |
|
| |||||||||
| Total | |||||||||
| F: | Range: | 1: | 1: | 1: | 1: | 1: | Range: | ||
A: M = male, F = female; B: 1 = extremely low, 2 = low, 3 = average, 4 = good; C: 1 = spasticity, 2 = ataxia, 3 = extremely delayed, 4 = delayed, 5 = normal development; D: 1 = nonambulation, 2 = nonfunctional ambulation, 3 = household ambulation, 4 = community ambulation, 5 = normal ambulation; E: 1 = no oral communication possible, 2 = communication with a known person, 3 = frequent repetitions, 4 = incidental repetitions, 5 = effective despite small problems, 6 = effective communication; F: 1 = not self-independent, 2 = minimal self-independent, 3 = sufficient self-independent, 4 = fully self-independent; G: the higher the score, the better the (by fatigue impacted) health-related quality of life, unknown = missing data; H: OPA1 = optic atrophy 1; FBXL = F-box and leucine-rich repeat proteins; SDHA = succinate dehydrogenase complex, subunit A; RARS2 = arginyl-tRNA synthetase 2; ATP6 = ATP synthase 6; MT-TL1 = mitochondrial tRNA leucine; MTFMT = mitochondrial methionyl-tRNA formyltransferase; TAZ = taffazin; NDUFS7 = NADH-ubiquinone oxidoreductase Fe-S protein 7; mt-tRNASer = mitochondrial tRNA serine.
Figure 1Activities, activity categories, and occupational performance areas of children with mitochondrial disorder.